Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Activation of the Spinal Muscular Atrophy Neonatal Screening Program and Integration With Cystic Fibrosis Screening. Feasibility Study

NCT06310421 is registered in ClinicalTrials.gov with IRCCS Burlo Garofolo as lead sponsor.

NCT NCT06310421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06310421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Activation of the Spinal Muscular Atrophy Neonatal Screening Program and Integration With Cystic Fibrosis Screening. Feasibility Study
Lead sponsor
IRCCS Burlo Garofolo
Phase
Observational
Overall status
Unknown status
Start date
October 16, 2023
Completion date
May 31, 2026
Enrollment
11,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy